Ginthör Noemi E, Artinger Katharina, Pollheimer Marion J, Stradner Martin H, Eller Kathrin
Division of Nephrology, Medical University of Graz, Graz, Austria.
Institute of Pathology, Medical University of Graz, Graz, Austria.
Clin Kidney J. 2021 Dec 8;15(3):564-566. doi: 10.1093/ckj/sfab250. eCollection 2022 Mar.
Immunoglobulin G4 (IgG4)-releated disease is typically associated with interstitial nephritis, but rare cases of idiopathic membranous nephropathy as a renal manifestation have been described. Obinutuzumab was successfully used in refractory membranous nephropathy, but evidence for the treatment of IgG4-related disease with obinutuzumab is lacking. We report one patient's case with membranous nephropathy associated with IgG4-related disease who was treated with obinutuzumab following an anaphylactic reaction to rituximab. Obinutuzumab treatment resulted in a sustained complete remission of membranous nephropathy and a decrease of IgG4 to the normal range. This case demonstrates that membranous nephropathy associated with IgG4-related disease can be treated successfully with obinutuzumab.
免疫球蛋白G4(IgG4)相关疾病通常与间质性肾炎有关,但也有罕见病例报道其可表现为特发性膜性肾病。奥滨尤妥珠单抗已成功用于治疗难治性膜性肾病,但缺乏其治疗IgG4相关疾病的证据。我们报告了1例与IgG4相关疾病相关的膜性肾病患者,该患者在对利妥昔单抗发生过敏反应后接受了奥滨尤妥珠单抗治疗。奥滨尤妥珠单抗治疗使膜性肾病持续完全缓解,且IgG4降至正常范围。该病例表明,奥滨尤妥珠单抗可成功治疗与IgG4相关疾病相关的膜性肾病。